Cargando…

Role of the levonorgestrel intrauterine system in effective contraception

Norgestrel, a synthetic progestin chemically derived from 19-nortestosterone, is six times more potent than progesterone, with variable binding affinity to various steroid receptors. The levonorgestrel-releasing intrauterine system (LNG IUS) provides a long-acting, highly effective, and reversible f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attia, Abdelhamid M, Ibrahim, Magdy M, Abou-Setta, Ahmed M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749061/ https://www.ncbi.nlm.nih.gov/pubmed/23990713 http://dx.doi.org/10.2147/PPA.S36948

Ejemplares similares

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling
por: Costescu, Dustin J
Publicado: (2016)

Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review
por: Zgliczynska, Magdalena, et al.
Publicado: (2020)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Cost‐effectiveness analysis of a low‐dose contraceptive levonorgestrel intrauterine system in Sweden
por: Henry, Nathaniel, et al.
Publicado: (2015)

Exploring the Role of Levonorgestrel Intrauterine System (LNG-IUS) as a Method of Emergency Contraception (EC)
por: Kumari, Snigdha, et al.
Publicado: (2022)

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
por: Shawki, Osama, et al.
Publicado: (2013)

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013)

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
por: Beatty, Megan N, et al.
Publicado: (2009)

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
por: de Oliveira, Elaine Cristina Fontes, et al.
Publicado: (2023)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
por: Kailasam, Chandra, et al.
Publicado: (2008)

More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years
por: Gemzell-Danielsson, Kristina, et al.
Publicado: (2021)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo
por: Cavrois, Marielle, et al.
Publicado: (2019)

Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience
por: Wildemeersch, Dirk, et al.
Publicado: (2017)

Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review
por: Zürcher, Aline, et al.
Publicado: (2022)

The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa
por: Hubacher, David
Publicado: (2015)

Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis
por: Sergison, Jill E., et al.
Publicado: (2019)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
por: Choi, Sangwon, et al.
Publicado: (2021)

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System—A Review of 10 Years of Clinical Experience
por: Wildemeersch, Dirk, et al.
Publicado: (2016)

The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011)

Effect of modified levonorgestrel‐releasing intrauterine system in human adenomyosis with heavy menstrual bleeding
por: Yang, Hong, et al.
Publicado: (2021)

Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia
por: Gök, Soner, et al.
Publicado: (2022)

Effects of the levonorgestrel‐releasing intrauterine device on the immune microenvironment of the human cervix and endometrium
por: Shanmugasundaram, Uma, et al.
Publicado: (2016)

Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021)

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners
por: Nanda, Geeta, et al.
Publicado: (2018)

Provision of the levonorgestrel intrauterine system in Nigeria: Provider perspectives and service delivery costs
por: Brunie, Aurélie, et al.
Publicado: (2020)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
por: Gunardi, Eka Rusdianto, et al.
Publicado: (2022)

Retracted: Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
por: Lang, Benjamin, et al.
Publicado: (2018)

The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012
por: Bingham, Amie L., et al.
Publicado: (2018)

Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis
por: Cai, Yuru, et al.
Publicado: (2023)

Levonorgestrel-Releasing Intrauterine System versus Medical Therapy for Menorrhagia: A Systematic Review and Meta-Analysis
por: Qiu, Jin, et al.
Publicado: (2014)

Systematic review and meta‐analysis on the impact of the levonorgestrel‐releasing intrauterine system in reducing risk of ovarian cancer
por: D’Alessandro, Gloria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ldllsrk1l7ft1jl0ucsa2euim